Xcout IntelSign inSubscribe

ALLURION TECHNOLOGIES, INC. competitors & alternatives

ALURMedical DevicesNatick, United States

The 12 closest competitors and alternatives to ALLURION TECHNOLOGIES, INC. among medical devices companies — ranked by similarity to what ALLURION TECHNOLOGIES, INC. actually does, not by market-cap band.

$4.7MMarket cap
134Employees
12Competitors listed

Subscribe to see ALLURION TECHNOLOGIES, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About ALLURION TECHNOLOGIES, INC.

Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.

ALLURION TECHNOLOGIES, INC. at a glance

ALLURION TECHNOLOGIES, INC. is a medical devices company headquartered in Natick, United States. It is publicly listed (ALUR) with a market capitalisation of $4.7M. Xcout tracks 34 named people at ALLURION TECHNOLOGIES, INC., including Ojas A. Buch (Chief Operating Officer).

ALLURION TECHNOLOGIES, INC. leadership

  • Ojas A. BuchChief Operating Officer
  • Keith JohnsChief Operating Officer at Adipo Therapeutics
  • Brendan Michael GibbonsChief Legal & People Officer and Secretary
  • Brendan GibbonsChief Legal Officer
  • Shantanu K. GaurCo-Founder, Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
  • Dr. Shantanu GaurChief Executive Officer and Co-Founder

28 more named people on record for ALLURION TECHNOLOGIES, INC., with roles, board committees and tenure — see the full roster →

Top 12 ALLURION TECHNOLOGIES, INC. competitors

Ranked by semantic similarity — how close each company is to ALLURION TECHNOLOGIES, INC. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Boston Scientific0HOY · Medical DevicesMarlborough, United States
62% matchPublic

Similar medical devices company

Boston Scientific Corporation operates as a global medical technology firm, specializing in the design, production, and worldwide distribution of innovative medical devices tailored for various interventional specialties. The company's operations are strategically divided into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Through its MedSurg division, Boston Scientific provides critical diagnostic and therapeutic tools aimed at addressing conditions affecting the gastrointestinal and pulmonary systems, alongside a diverse portfolio of solutions for urological and pelvic health issues. The Rhythm and Neuro segment is dedicated to advanced cardiac rhythm management and neurological interventions. Its product offerings encompass implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) defibrillators, and pacemakers (including CRT pacemakers), all complemented by remote patient monitoring platforms. This segment also delivers sophisticated technologies for assessing and treating cardiac rate and rhythm irregularities, featuring solutions such as 3-D mapping and navigation systems, various ablation and diagnostic catheters, intracardiac ultrasound catheters, and related accessories. In the neurological domain, it furnishes spinal cord stimulator systems for managing chronic pain, indirect decompression systems, and deep brain stimulation systems. Boston Scientific's Cardiovascular segment presents an extensive array of products focused on heart and vascular health. This includes cutting-edge interventional cardiology solutions like drug-eluting coronary stent systems for treating coronary artery disease, as well as percutaneous coronary intervention (PCI) instruments designed to tackle atherosclerosis. The segment further provides intravascular catheter-directed ultrasound imaging and fractional flow reserve (FFR) devices, applicable in coronary arteries, heart chambers, and peripheral vessels, in addition to structural heart therapies. Beyond this, the company supplies stents, balloon catheters, wires, and atherectomy systems for arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents for venous conditions; and a comprehensive suite of products for cancer treatment, including peripheral embolization devices, radioactive microspheres, various ablation systems (such as cryotherapy), and micro/drainage catheters. Established in 1979, the corporation maintains its headquarters in Marlborough, Massachusetts.

Market cap$65.2B
Employees59,000
Boston Scientific competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of ALLURION TECHNOLOGIES, INC. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for ALLURION TECHNOLOGIES, INC.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →